These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment. Soto E; Shoji S; Muto C; Tomono Y; Marshall S Br J Clin Pharmacol; 2014 Mar; 77(3):509-21. PubMed ID: 24102758 [TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult Patients. Setiawan E; Cotta MO; Abdul-Aziz MH; Widjanarko D; Sosilya H; Lukas DL; Wallis SC; Parker S; Roberts JA Clin Pharmacokinet; 2023 Apr; 62(4):573-586. PubMed ID: 36853585 [TBL] [Abstract][Full Text] [Related]
6. Effect of Blood Product Resuscitation on the Pharmacokinetics of Ampicillin-Sulbactam during Orthotopic Liver Transplantation. Lasko MJ; Serrano OK; Kois AK; Nicolau DP; Kuti JL Surg Infect (Larchmt); 2022 Mar; 23(2):119-126. PubMed ID: 34818052 [No Abstract] [Full Text] [Related]
7. Comparison of the pharmacokinetics of continuous and intermittent infusions of ampicillin-sulbactam in dogs with septic peritonitis. Stewart SD; Allen S; Eisenberg B; Sakakeeny K; Hammond TN; Schneider B; Mochel J; Zhou T Am J Vet Res; 2022 Dec; 84(2):. PubMed ID: 36520648 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients. De Waele JJ; Lipman J; Akova M; Bassetti M; Dimopoulos G; Kaukonen M; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Udy AA; Starr T; Wallis SC; Roberts JA Intensive Care Med; 2014 Sep; 40(9):1340-51. PubMed ID: 25053248 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including Onita T; Ikawa K; Ishihara N; Tamaki H; Yano T; Naora K; Morikawa N Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830214 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass. Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Yamamoto H; Imoto Y; Morikawa N; Takeda Y Biol Pharm Bull; 2015; 38(11):1817-21. PubMed ID: 26521833 [TBL] [Abstract][Full Text] [Related]
12. Ampicillin/sulbactam: its potential use in treating infections in critically ill patients. Adnan S; Paterson DL; Lipman J; Roberts JA Int J Antimicrob Agents; 2013 Nov; 42(5):384-9. PubMed ID: 24041466 [TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics and Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam in Critically Ill Patients with Severe Sepsis Caused by Acinetobacter baumannii. Jaruratanasirikul S; Wongpoowarak W; Wattanavijitkul T; Sukarnjanaset W; Samaeng M; Nawakitrangsan M; Ingviya N Antimicrob Agents Chemother; 2016 Dec; 60(12):7236-7244. PubMed ID: 27671056 [TBL] [Abstract][Full Text] [Related]
14. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii. Housman ST; Hagihara M; Nicolau DP; Kuti JL J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacokinetics of piperacillin and sulbactam during intermittent and continuous intravenous infusion. Langgartner J; Lehn N; Glück T; Herzig H; Kees F Chemotherapy; 2007; 53(5):370-7. PubMed ID: 17785973 [TBL] [Abstract][Full Text] [Related]
16. The clinical and paraclinical effectiveness of four-hour infusion vs. half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: An assessor-blinded randomized clinical trial. Mirjalili M; Zand F; Karimzadeh I; Masjedi M; Sabetian G; Mirzaei E; Vazin A J Crit Care; 2023 Feb; 73():154170. PubMed ID: 36272277 [TBL] [Abstract][Full Text] [Related]
17. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhao C; Xie W; Zhang W; Ye Z; Wu H Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663 [TBL] [Abstract][Full Text] [Related]
18. Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study. Ehmann L; Zoller M; Minichmayr IK; Scharf C; Maier B; Schmitt MV; Hartung N; Huisinga W; Vogeser M; Frey L; Zander J; Kloft C Crit Care; 2017 Oct; 21(1):263. PubMed ID: 29058601 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam. Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of synergistic activity of antibiotic combinations in extensive drug-resistant Abdel Halim RM; Saber SM; Fahim NAE J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36762530 [No Abstract] [Full Text] [Related] [Next] [New Search]